Consolidated Statements of Operations - USD ($) shares in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023
Revenue		$ 2,378,000	$ 3,810,000
Cost of revenue (exclusive of depreciation, amortization, and casualty gain)		2,047,000	2,899,000
Gross profit		331,000	911,000
Operating expenses (gain):
Research and development		155,000	20,000
Sales and marketing		181,000	309,000
General and administrative		4,197,000	4,870,000
Impairment charges		0	262,000
Casualty gain		0	(400,000)
Depreciation and amortization		0	345,000
Total operating expenses		4,533,000	5,406,000
Loss from operations		(4,202,000)	(4,495,000)
Interest and other income, net
Interest and other expense		0	28,000
Interest and other income		(169,000)	(166,000)
Total interest and other income, net	[1]	(169,000)	(138,000)
Loss before income taxes	[1]	(4,033,000)	(4,357,000)
Income tax expense		10,000	27,000
Net loss		(4,043,000)	(4,384,000)
Preferred stock dividends		89,000	343,000
Warrants, deemed dividend		8,974,000	0
Induced conversion of warrants		0	751,000
Warrant modification		0	25,000
Net loss attributable to common stockholders		$ (13,106,000)	$ (5,503,000)
Net loss attributable to common stockholders per share:
Basic and diluted net loss per share (in dollars per share)		$ (15.71)	$ (18.81)
Weighted-average number of shares of common stock:
Basic and diluted (in shares)		834	293

[1] Other income (expense) for our segments includes interest expense and non-operating income. Corporate other income includes interest income on our cash and cash equivalents.